On 20 May Inhalation Sciences AB CSO Per Gerde presented the company's predictive tools for developing and assessing generic inhaled pharmaceuticals at the
ISAB's webinar session at the workshop was titled "Predictive Tools for
Engagement in the session was high - the annual GDUFA workshops are open and audience members can provide prepared or impromptu comments.
ISAB's presentation included the company's unique platform technology PreciseInhale®, ISAB's in vitro tool for evaluating the dissolution and absorption of aerosols, DissolvIt®, and also Isolated Perfused Lung (IPL), a specially tailored version of the system designed specifically for aerosols generated by the company's PreciseInhale® aerosol generation R&D system.
ISAB CEO Manoush Masarrat: "this was a great meeting where we had the pleasure to present and interact with an expert and venerable audience of fellow inhalation scientists. We are pleased to have been invited and we would like to thank the FDA and everyone who took part".
Read more about DissolvIt®
Read ISAB's publications on DissolvIt® here.
Read about DissolvIt's in vitro capabilities here.
Read more about IPL
Read more about IPL here.
For more information on Inhalation Sciences, please contact:
Manoush Masarrat, CEO
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153
About
https://news.cision.com/inhalation-sciences/r/inhalation-sciences-presents-at-well-received-fda-public-workshop-gdufa,c3985915
https://mb.cision.com/Main/15842/3985915/2813788.pdf
(c) 2024 Cision. All rights reserved., source